How many insider trades does FilingIQ track for NURO?

FilingIQ tracks 177 Form 4 insider transactions for NURO (NeuroMetrix, Inc.), covering filings from Mar 10, 2015 onwards. 0 of those were filed in the last 90 days.

Are NURO insiders net buyers or net sellers?

Across the full Form 4 history for NURO, 64 transactions (36%) were open-market purchases and 4 (2%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does NURO insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is NURO in?

NeuroMetrix, Inc. (NURO) is classified in the Healthcare sector, specifically Medical Devices.

NURO insider trading

NasdaqGM Healthcare

NeuroMetrix, Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

177

Last 90 days

Buys / sells

36% / 2%

Market cap

—

About NeuroMetrix, Inc.

NeuroMetrix, Inc., a commercial stage neurotechnology company, engages in designing and sale of medical devices. Its marketed products include DPNCheck, a nerve conduction test that is used to evaluate peripheral neuropathies, such as diabetic peripheral neuropathy; and Quell, a wearable device for symptomatic relief and management of chronic pain. The company offers its products to managed endocrinologists, podiatrists, primary care physicians, and other clinicians at the point-of care to objectively detect, stage, and monitor peripheral neuropathies. NeuroMetrix, Inc. was incorporated in 1996 and is headquartered in Woburn, Massachusetts.

Company website: www.neurometrix.com

NURO insider activity at a glance

FilingIQ has scored 177 insider transactions for NURO since Mar 10, 2015. The most recent filing in our index is dated May 1, 2025.

Across the full history, 64 open-market purchases and 4 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on NURO insider trades is 59.6/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live NURO trades on FilingIQ Raw filings on SEC EDGAR

Other Healthcare tickers with recent insider activity

UTHR 795

UNITED THERAPEUTICS Corp

KYMR 165

Kymera Therapeutics, Inc.

THERMO FISHER SCIENTIFIC INC.

Frequently asked

How many insider trades does FilingIQ track for NURO?: FilingIQ tracks 177 Form 4 insider transactions for NURO (NeuroMetrix, Inc.), covering filings from Mar 10, 2015 onwards. 0 of those were filed in the last 90 days.
Are NURO insiders net buyers or net sellers?: Across the full Form 4 history for NURO, 64 transactions (36%) were open-market purchases and 4 (2%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does NURO insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is NURO in?: NeuroMetrix, Inc. (NURO) is classified in the Healthcare sector, specifically Medical Devices.

Methodology & sources

Every NURO insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.